LXer: OpenSpecimen moves disease study forward at the biobank
 

Published at LXer:

Access to high-quality human biospecimens such as blood, saliva, plasma, DNA, and RNA is integral to developing a better understanding of diseases and advancing molecular technologies, clinical trial research, personalized medicine research, and clinical practice.

Read More...